Chronic osteomyelitis is a bone infection that has persisted long enough for bacteria to establish deep, self-protecting reservoirs inside the bone tissue itself, making it far harder to eradicate than a typical infection. In the United States, osteomyelitis has reached a prevalence of roughly 22 per 100,000 people, with heavier burdens in older adults and those with chronic conditions like diabetes.1Open Forum Infectious Diseases. Osteomyelitis-Related Mortality Rates Increased From 1999 to 2023 in the US What makes the chronic form so stubborn has a lot to do with how bacteria reshape their environment once they settle into bone, and treating it almost always requires both surgery and prolonged antibiotics.
How Bacteria Reach the Bone
Bone infections arrive by two main routes. In hematogenous osteomyelitis, bacteria travel through the bloodstream from an infection elsewhere in the body and seed in bone. This is the more common pathway in children. In adults, the infection usually starts from a contiguous source: an open fracture, a surgical site, or an overlying soft-tissue wound that allows bacteria direct access to bone.2PubMed Central. Osteomyelitis of the long bones Diabetic foot ulcers are a particularly common gateway. Diabetic foot osteomyelitis develops in more than 20% of moderate diabetic foot infections and 50 to 60% of severe ones, and it carries high amputation rates.3Diabetes, Metabolic Syndrome and Obesity. Optimal management of diabetic foot osteomyelitis: challenges and solutions
Staphylococcus aureus dominates the microbiology of bone infections. In hematogenous cases, a single organism is almost always recovered, and S. aureus is the most common.2PubMed Central. Osteomyelitis of the long bones Chronic cases that develop after trauma or surgery paint a messier picture: gram-negative bacteria and mixed flora account for more than half of chronic osteomyelitis isolates, though S. aureus remains the single most frequently identified pathogen at about 39%.4PubMed Central. Chronic Osteomyelitis – Bacterial Flora, Antibiotic Sensitivity and Treatment Challenges That same study found that 83% of S. aureus isolates were resistant to oxacillin, placing them in the MRSA category. These resistance rates matter because they limit which antibiotics will work and often push treatment toward more expensive or more toxic alternatives.
Why the Infection Becomes So Hard to Clear
Acute bone infections can usually be cured with a course of antibiotics if caught early. The chronic form is a different animal. Once bacteria have been in bone for weeks to months, they deploy survival strategies that antibiotics and the immune system struggle to overcome.
The first problem is biofilm. Bacteria coat themselves and bone surfaces with a sticky matrix of sugars and proteins that acts as a physical shield. Antibiotics have trouble penetrating it, and immune cells cannot effectively reach the bacteria hiding underneath. Biofilm maturation is what clinically defines the transition from acute to chronic infection, a process generally recognized to occur somewhere between three weeks and three months.5Injury. Antimicrobial resistance: Biofilms, small colony variants, and intracellular bacteria
The second problem is that S. aureus can invade and survive inside bone cells themselves. Researchers have documented the bacterium living within osteoblasts (bone-building cells), osteoclasts (bone-resorbing cells), and osteocytes (mature bone cells embedded in the bone matrix). Once inside these cells, the bacteria sit in an immune-privileged space where neither antibodies nor many antibiotics can easily reach them. An infected osteoblast that matures into an osteocyte may effectively seal bacteria behind mineralized bone, creating a long-term reservoir.5Injury. Antimicrobial resistance: Biofilms, small colony variants, and intracellular bacteria
A third reservoir was discovered more recently. Electron microscopy in animal models showed S. aureus colonizing the tiny channels and spaces within bone tissue, the lacuno-canalicular network, that normally house osteocyte cell processes. The bacteria were found inside canaliculi and lacunar spaces from which osteocytes had already died.6PubMed Central. Evolving concepts in bone infection: redefining “biofilm”, “acute vs. chronic osteomyelitis”, “the immune proteome” and “local antibiotic therapy” This microscopic infiltration explains why even aggressive surgical cleaning sometimes fails to fully eradicate the infection: bacteria can hide in spaces too small for a surgeon’s instrument to reach.
All of these mechanisms together explain a hallmark of chronic osteomyelitis: it tends to run as a low-grade, smoldering inflammation rather than an obvious acute illness. Patients may go through stretches of relative quiet punctuated by flare-ups that drain through the skin, sometimes for years.
What Happens to the Bone Itself
Chronic infection triggers a destructive cascade. Sections of bone can lose their blood supply through blood vessel clotting or direct bacterial damage, causing them to die. A piece of dead bone walled off from living tissue is called a sequestrum. It sits inside the body as essentially a foreign object, unreachable by blood-borne antibiotics or immune cells, and serves as yet another bacterial hideout.7PubMed. Sequestration and Involucrum: Understanding Bone Necrosis and Revascularization in Pediatric Orthopedics The body often responds by laying down new bone around the dead area, a shell called an involucrum. These features are visible on imaging and are part of what surgeons look for when planning treatment.
Meanwhile, the intracellular infection of bone cells by S. aureus triggers the release of signaling molecules that activate osteoclasts, the cells responsible for breaking down bone. The result is progressive pathological bone loss on top of whatever destruction the infection itself causes.5Injury. Antimicrobial resistance: Biofilms, small colony variants, and intracellular bacteria Over time, this can weaken the bone structurally and create cavities, or “dead space,” that become their own management challenge during treatment.
Recognizing Chronic Osteomyelitis
Unlike acute osteomyelitis, which often presents with fever, severe pain, and obvious swelling, the chronic form is subtler. Pain may be persistent but not dramatic. The most characteristic sign is a draining sinus tract: a channel from the infected bone through soft tissue to the skin surface, through which pus or fluid intermittently drains. A study of patients with bone and joint infection who had sinus tracts found their physical quality-of-life scores were significantly worse than the general population, while their mental health scores were comparable.8PubMed Central. The Sinus Tract in Bone and Joint Infection: Minimally Invasive Salvation or Prolonged Suffering? A Multicenter Study In other words, the disease takes a real physical toll, even when patients are psychologically adapting to it.
Other common features include localized warmth, redness, and swelling over the affected bone, along with occasional low-grade fevers. Some people develop chronic fatigue. The infection can go dormant for months or even years, only to reactivate after an illness, injury, or decline in immune function.
Getting the Diagnosis Right
Confirming chronic osteomyelitis and identifying the exact bacteria responsible are two separate challenges, and both matter for treatment.
For imaging, MRI has long been a workhorse. In one head-to-head comparison with dual-energy CT for lower-limb osteomyelitis, MRI achieved about 89% sensitivity and 88% specificity.9PubMed Central. Osteomyelitis of the Lower Limb: Diagnostic Accuracy of Dual-Energy CT versus MRI PET-CT scanning, which uses a radioactive glucose tracer to highlight areas of increased metabolic activity, has shown even higher numbers in some reports, with sensitivity reaching 94% and specificity up to 100%, and it can help surgeons plan exactly how much bone to remove.10Orthopaedic Proceedings. ROLE OF 18F-FDG PET-CT IN PREOPERATIVE PLANNING OF SURGICAL DEBRIDEMENT IN CHRONIC OSTEOMYELITIS The choice of imaging depends on what is available and what the surgeon needs to see, since MRI excels at soft-tissue detail while PET-CT is better at mapping the full extent of metabolically active infection.
Identifying the causative bacteria is arguably more critical. The gold standard is culturing a sample of the infected bone itself, obtained during surgery or through a needle biopsy. Surface swabs and cultures from non-bone tissues are unreliable: one study found only 28% concordance between non-bone specimens and bone cultures, with 52% false negatives and 36% false positives when non-bone cultures were compared against bone.11PubMed Central. Lack of microbiological concordance between bone and non-bone specimens in chronic osteomyelitis: an observational study Even deep tissue cultures in diabetic foot osteomyelitis matched bone cultures only about 52% of the time.12PubMed Central. Are Deep Tissue Cultures a Reliable Alternative to Bone Biopsy for Diagnosing Diabetic Foot Osteomyelitis? A Comparative Diagnostic Study Sinus tract cultures, however, showed the highest agreement with bone biopsy among non-bone sampling methods.13Journal of Infection and Public Health. Concordance of bone and non-bone specimens in microbiological diagnosis of osteomyelitis: A systematic review and meta-analysis The practical takeaway: if your doctor is treating chronic osteomyelitis based solely on a wound swab, the antibiotic chosen may be targeting the wrong organism.
Surgical Treatment
Surgery is the cornerstone for most cases of chronic osteomyelitis. The principal goal is to remove all dead, infected, and poorly vascularized bone and soft tissue, a procedure called debridement. Any sequestra must come out, since dead bone will harbor bacteria indefinitely. After debridement, the surgeon faces the problem of dead space: the cavity left behind needs to be filled, or it will fill with blood and fluid that can become a breeding ground for new infection.
Muscle flaps are one of the most effective solutions. Surgeons can rotate a nearby muscle into the defect or transplant one from elsewhere in the body using microsurgical techniques. The muscle brings its own blood supply, which delivers antibiotics and immune cells directly into the formerly dead zone. Studies have consistently shown that bone debridement combined with a muscle flap produces better outcomes than debridement alone.14PubMed Central. Factors predictive of relapse in adult bacterial osteomyelitis of long bones In complex scenarios like midfoot osteomyelitis from a ballistic injury, surgeons have successfully used a free muscle flap sculpted to fit an irregular cavity, achieving infection-free status at 12-month follow-up.15PubMed. Segmental Cylindrical Gracilis Free Flap for Dead Space Obliteration in Chronic Midfoot Osteomyelitis Secondary to Ballistic Injury: A Case Report
Antibiotics and the IV-Versus-Oral Debate
Traditionally, chronic osteomyelitis was treated with weeks of intravenous antibiotics, often through a long-term central line, followed by additional weeks of oral drugs. This approach is burdensome: it usually requires prolonged hospital stays or home IV therapy, with risks of line infections and blood clots.
A landmark trial published in the New England Journal of Medicine compared oral antibiotics to IV antibiotics for bone and joint infections (including osteomyelitis) and found them equally effective. Treatment failure occurred in about 15% of the IV group and 13% of the oral group, and oral therapy met the statistical bar for non-inferiority.16PubMed Central. Oral versus Intravenous Antibiotics for Bone and Joint Infection A more recent meta-analysis pooling data from multiple randomized trials confirmed these results: oral and IV therapies showed comparable rates of treatment failure and adverse events.17Bone. Oral versus intravenous antibiotics for bone and joint infections: Systematic review and meta-analysis of randomized controlled trials
This does not mean every patient can skip the IV. The choice of antibiotic matters enormously. Oral options need to penetrate bone well, and not all oral drugs do. Fluoroquinolones, rifampin combinations, and certain newer agents have good bone penetration, while others do not. The decision is also shaped by the resistance profile of the specific organism, which brings us back to the importance of a bone culture. But for many patients, these findings have meant shorter hospital stays and fewer line-related complications.
Local Antibiotic Delivery
Beyond systemic antibiotics, surgeons often place antibiotic-loaded materials directly into the bone defect after debridement. The most established option is PMMA (polymethylmethacrylate) bone cement mixed with antibiotics like vancomycin or gentamicin. It has been used for decades, but it has drawbacks: antibiotic release drops below effective levels within about two weeks, the cement does not dissolve on its own and may require a second surgery for removal, and its surface can actually attract biofilm-forming bacteria once antibiotic levels wane.18PubMed Central. Effectiveness of an Antibiotic-impregnated Bioabsorbable Carrier for the Treatment of Chronic Intramedullary and Diffuse Osteomyelitis
Biodegradable alternatives, particularly calcium sulfate beads, address several of these problems. They dissolve in the body over weeks, releasing antibiotics for roughly 40 to 42 days, and they do not need a second surgery for removal.19PubMed Central. Local Antibiotic Delivery Systems and Their Applications in Orthopaedic Surgery A recent comparative study found that combining PMMA with calcium sulfate achieved significantly higher infection control rates (about 87% versus 72% with PMMA alone) and lower reoperation rates.20PubMed Central. A retrospective cohort study comparing the effects on inflammatory response and clinical outcomes of vancomycin-PMMA versus vancomycin-sulfate calcium in chronic osteomyelitis The field is moving toward these resorbable carriers, though PMMA remains widely used where biodegradable options are unavailable.
What Predicts Relapse
Even with surgery and appropriate antibiotics, chronic osteomyelitis recurs in a meaningful percentage of patients. A study of long-bone osteomyelitis in adults identified three factors that strongly predicted relapse: infection duration beyond three months before treatment, exposed bone through an open wound, and the type of surgery performed. Patients who had debridement with a muscle flap did significantly better than those treated with debridement alone, and both groups fared better than those who received no surgery at all.14PubMed Central. Factors predictive of relapse in adult bacterial osteomyelitis of long bones
The message is clear: early and aggressive intervention reduces the chance of recurrence. Patients who delay treatment or who have limited surgical options face a harder road. A modified staging system that accounts for host health factors (immune status, blood supply to the limb, presence of diabetes or peripheral vascular disease) has helped surgeons tailor treatment intensity, achieving about 90% short-term success across both high-risk and low-risk patients when treatment was matched to the stage.21PubMed Central. A modified staging system for chronic osteomyelitis
Hyperbaric Oxygen as an Add-On
Hyperbaric oxygen therapy, in which a patient breathes pure oxygen in a pressurized chamber, has been used as an adjunct for refractory cases that do not respond to standard surgery and antibiotics. The idea is that flooding infected tissue with oxygen enhances immune cell killing of bacteria and promotes healing of compromised bone and soft tissue. No randomized controlled trials have been completed to date, but a comprehensive literature review concluded that adding hyperbaric oxygen to surgery and culture-directed antibiotics appears safe and improves infection resolution in cases that had previously failed treatment.22PubMed. Hyperbaric oxygen for refractory osteomyelitis The best results are seen when it is started soon after surgical debridement rather than used as a standalone rescue measure.23Undersea and Hyperbaric Medicine. Hyperbaric oxygen for refractory osteomyelitis It remains a second-line option reserved for difficult cases, not a routine part of treatment.
The Burden Beyond the Bone
Chronic osteomyelitis takes a toll that extends well past the infection itself. Treatment courses often span months or years, involving multiple surgeries, long antibiotic regimens, and periods of limited mobility. Research has documented that patients face chronic pain, difficulty walking, and psychological distress including fear of disease progression and financial strain from repeated treatments.24PubMed Central. The association between fear of disease progression and financial toxicity in patients with chronic osteomyelitis: a cross-sectional study In the United States, osteomyelitis-related mortality has actually increased from 1999 to 2023, likely driven by the aging population and the rising prevalence of diabetes and other conditions that make bone infections both more likely and harder to treat.1Open Forum Infectious Diseases. Osteomyelitis-Related Mortality Rates Increased From 1999 to 2023 in the US
Marjolin’s Ulcer and Other Long-Term Complications
When chronic osteomyelitis persists for many years, a rare but serious complication can develop: squamous cell carcinoma arising in chronically inflamed tissue, known as Marjolin’s ulcer. The cancer forms in the soft tissue surrounding the bone infection, usually after years or decades of ongoing inflammation and draining sinus tracts.25PubMed. Marjolin’s ulcer associated with chronic osteomyelitis Any draining wound that suddenly changes character, grows rapidly, or bleeds more than usual in the setting of longstanding osteomyelitis should be biopsied to rule out malignancy.
Other long-term problems include chronic limb deformity from bone loss, pathological fractures through weakened bone, joint stiffness from prolonged immobilization, and amyloidosis in very long-standing cases, a condition where abnormal protein deposits accumulate in organs in response to decades of chronic inflammation. The jaw presents its own set of risks: chronic suppurative osteomyelitis of the mandible in children aged 6 to 12 and adults over 65, along with concurrent infections of surrounding facial spaces, has been associated with higher recurrence rates.26PubMed Central. Risk factors of recurrence and life-threatening complications for patients hospitalized with chronic suppurative osteomyelitis of the jaw The jaw’s dense blood supply and proximity to the teeth create a distinct environment where dental pathology can seed and perpetuate infection differently than in long bones.